A new study published in European Heart Journal found patients with stable or controlled coronary artery disease (CAD) who have a diastolic blood pressure reading of 80-89 mmHg may have an increased risk for cardiovascular disease (CVD). A systolic blood pressure reading of 130-139 mmHg was not associated with an increased risk for CVD.
Patients who were prescribed a single pill with low doses of three antihypertensive medications reached their blood pressure (BP) targets more often than those following a usual care plan, according to a randomized trial of 700 individuals from the Sri Lankan public health system.
Sodium intake is associated with cardiovascular disease (CVD) only in communities where the average intake is more than five grams per day, according to an update of the Prospective Urban Rural Epidemiology (PURE) study published in The Lancet.
New preliminary research suggests young women who exhibit obesity may have heart complications during and after pregnancy, including changes in heart structure and function—potentially leading to preeclampsia. Findings were presented at the American Heart Association’s Basic Cardiovascular Sciences Scientific Sessions.
Moderately elevated levels of LDL cholesterol and systolic blood pressure (SBP) that persist for a long time are just as dangerous as very elevated values over a shorter timeframe, according to a new study published in PLOS One.
Intensive blood pressure lowering helped reduce the risk of mild cognitive impairment (MCI), according to a substudy from the SPRINT trial presented last week at the Alzheimer’s Association International Conference in Chicago.
A hypertension management protocol from an integrated healthcare system was successfully adopted by a network of safety-net clinics, resulting in substantial improvements in blood pressure control for patients of all races.
The FDA on Friday, July 13, joined more than 20 other countries in recalling medications containing valsartan, an active ingredient used to treat hypertension and heart failure. Some of the medications with valsartan have been contaminated with N-nitrosodimethylamine (NDMA), a probable human carcinogen.
Adoption of the new 2017 American College of Cardiology/American Heart Association (ACC/AHA) hypertension guidelines would result in a “substantial” increase in the prevalence of hypertension in both the U.S. and China.
Valsartan, a common drug used to control hypertension and heart failure, is being recalled in 22 counties due to concerns its active pharmaceutical ingredient, N-Nitrosodimethylamine (NDMA), a known carcinogen, poses a cancer risk.
A program designed to help hypertensive patients with complex medication regimens understand the drugs they are prescribed not only failed to improve adherence, but it actually raised their blood pressure.
Patients with resistant hypertension and obstructive sleep apnea (OSA) experienced significant drops in blood pressure and improvements in OSA severity following renal denervation, according to a small randomized trial published June 25 in Hypertension.
According to a new study published in the Journal of the American College of Cardiology, women with preeclampsia with severe features (PEC) have higher right ventricular (RV) systolic pressure (RVSP) and decreased global right ventricular longitudinal systolic strain (RVLSS), among other adverse cardiovascular events, compared to women not exhibiting preeclampsia during pregnancy.
Sleep disturbances, including poor sleep quality and insomnia, are associated with increased blood pressure and vascular inflammation in women, according to a June 9 study in the Journal of the American Heart Association.
A new study published in Hypertension suggests tailoring blood pressure (BP) treatment to a patient’s exercise level may help, because people with elevated but controlled hypertension saw an increase in BP during physical activity.
Frequent binge drinkers—particularly men—are more likely to have cardiovascular risk factors such as hypertension and high cholesterol, according to a new study published in the Journal of the American Heart Association.
Systolic blood pressures above 130 millimeters of mercury in middle age were associated with an increased risk of dementia later on, according to a longitudinal study published June 12 in the European Heart Journal.